We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S.-EU Partnership on GMP Inspections Adds Five Countries
U.S.-EU Partnership on GMP Inspections Adds Five Countries
The FDA has agreed to recognize drug and active pharmaceutical ingredient GMP inspections carried out by authorities in Belgium, Denmark, Finland, Latvia and Estonia, updating the 1998 mutual recognition agreement between the U.S. and the European Union.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor